HEPATITIS C, CHRONIC

Clinical trials for HEPATITIS C, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS C, CHRONIC trials appear

Sign up with your email to follow new studies for HEPATITIS C, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Completed 6

New hep c pill combo takes on standard therapy in major trial

Disease control Recruiting now

This study compares a new oral medication, Bemnifosbuvir-Ruzasvir, to the current standard treatment, Sofosbuvir-Velpatasvir, for adults with chronic hepatitis C. About 880 participants who have not taken similar drugs before will receive one of the two treatments. The main goal …

Matched conditions: HEPATITIS C, CHRONIC

Phase: PHASE3 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

HEPATITIS C, CHRONIC

Get alerted when new HEPATITIS C, CHRONIC trials appear

New hep c pill combo takes on standard therapy in major trial